{"id":71090,"date":"2025-09-09T12:00:00","date_gmt":"2025-09-09T12:00:00","guid":{"rendered":"https:\/\/www.africa-press.net\/senegal\/politique\/alzheimer-la-france-refuse-le-traitement-leqembi"},"modified":"2025-09-10T00:15:50","modified_gmt":"2025-09-10T00:15:50","slug":"alzheimer-la-france-refuse-le-traitement-leqembi","status":"publish","type":"post","link":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi","title":{"rendered":"Alzheimer: la France Refuse le Traitement Leqembi"},"content":{"rendered":"<p><span style=\"color: #ff6600\"><strong>Africa-Press &#8211; Senegal. <\/strong><\/span>Le Leqembi, un nouveau traitement contre la maladie d\u2019Alzheimer, ne sera pas rembourse\u0301 dans l\u2019imme\u0301diat en France. Sa Haute autorite\u0301 de sante\u0301 (HAS) se montre sceptique, e\u0301voquant des effets secondaires bien trop lourds au regard de be\u0301ne\u0301fices insignifiants. \u00ab L\u2019acce\u0300s pre\u0301coce a\u0300 Leqembi n\u2019a pas e\u0301te\u0301 retenu \u00bb, a re\u0301sume\u0301 Pierre Cochat, pre\u0301sident de la commission de la transparence de la HAS, a\u0300 l\u2019occasion d\u2019un avis rendu le 9 septembre par l\u2019institution et tre\u0300s attendu par les spe\u0301cialistes de la maladie d\u2019Alzheimer, la plus courante des de\u0301mences avec des dizaines de millions de malades dans le monde.<\/p>\n<p>Le Leqembi (le\u0301cane\u0301mab), de\u0301veloppe\u0301 par les laboratoires Biogen et Eisai, est l\u2019un des principaux espoirs auxquels s\u2019accrochent les associations de patients et de proches, ainsi qu\u2019un traitement au fonctionnement semblable, le Kisunla (donane\u0301mab) d\u2019Eli Lilly. Lors de leurs essais cliniques, ces me\u0301dicaments ont permis de ralentir le\u0301ge\u0300rement le de\u0301clin de patients dont la maladie commenc\u0327ait. Nombre de spe\u0301cialistes y voient donc une avance\u0301e majeure, alors que la recherche de me\u0301dicaments anti-Alzheimer patine depuis des de\u0301cennies.<\/p>\n<p>Mais d\u2019autres regrettent un espoir illusoire, estimant que les be\u0301ne\u0301fices observe\u0301s sont si maigres qu\u2019ils ne font pas de diffe\u0301rence pour les patients, d\u2019autant que des effets graves et parfois mortels \u2013 he\u0301morragies et \u0153de\u0300mes ce\u0301re\u0301braux \u2013 sont clairement ave\u0301re\u0301s.<\/p>\n<p><b>Vive controverse<\/b><\/p>\n<p>Selon ces sceptiques, la faible efficacite\u0301 de ces me\u0301dicaments signifie que la recherche se concentre depuis trop longtemps sur une piste inade\u0301quate, suivie par Leqembi comme Kisunla: chercher a\u0300 limiter la formation de plaques de prote\u0301ines dites amyloi\u0308des dans le cerveau des malades.<\/p>\n<p>La HAS, dont les avis sont consultatifs mais ge\u0301ne\u0301ralement suivis par le gouvernement, s\u2019exprime donc a\u0300 un moment ou\u0300 la controverse reste vive et ou\u0300 d\u2019autres autorite\u0301s sanitaires se sont de\u0301ja\u0300 prononce\u0301es. Les Etats-Unis ont de\u0301ja\u0300 approuve\u0301 ces traitements et l\u2019Union europe\u0301enne (UE) a fait de me\u0302me. Mais, apre\u0300s avoir initialement refuse\u0301 son feu vert, celle-ci n\u2019a finalement donne\u0301 son approbation qu\u2019au printemps dernier, la restreignant aux patients les moins a\u0300 risque d\u2019effets graves.<\/p>\n<p>Surtout, autorisation ne veut pas dire remboursement, et ce alors que ces me\u0301dicaments ont un cou\u0302t e\u0301leve\u0301: ils cou\u0302tent plusieurs dizaines de milliers de dollars par an aux Etats-Unis. Signe que la distinction est importante, le Royaume-Uni a de\u0301c\u0327u les associations en autorisant ces traitements sur le principe, mais sans valider leur remboursement.<\/p>\n<p>C\u2019est sur ce dernier point que la HAS devait se prononcer et, plus spe\u0301cifiquement, sur le bien-fonde\u0301 d\u2019un \u00ab acce\u0300s pre\u0301coce \u00bb. Celui-ci signifie que le me\u0301dicament peut, de\u0300s maintenant, e\u0302tre rembourse\u0301 a\u0300 un prix fixe\u0301 par son fabricant. Cela permet de ne pas attendre la proce\u0301dure normale. L\u2019inte\u0301re\u0302t est pour les patients de disposer d\u2019un traitement innovant, et pour le laboratoire de vite commercialiser son me\u0301dicament.<\/p>\n<p><b>Be\u0301ne\u0301fices \u00ab tre\u0300s insuffisants \u00bb<\/b><\/p>\n<p>Ce ne sera pas le cas pour le Leqembi. La HAS conclut, au vu des e\u0301tudes fournies par les laboratoires, que rien ne justifie d\u2019accorder un tel traitement de faveur. \u00ab On sait bien a\u0300 quel point tout le monde avait beaucoup d\u2019espoir \u00bb, a reconnu M. Cochat. Mais il met en regard des be\u0301ne\u0301fices \u00ab tre\u0300s insuffisants par rapport a\u0300 ce qu\u2019on attendait \u00bb avec \u00ab des effets secondaires qui ne sont pas faibles du tout \u00bb.<\/p>\n<p>Cela ne remet pas en cause la possibilite\u0301 que le Leqembi soit un jour rembourse\u0301 en France. La HAS, qui se prononcera d\u2019ici a\u0300 quelques mois sur l\u2019opportunite\u0301 d\u2019une proce\u0301dure normale, assure que rien n\u2019est exclu. Mais \u00ab c\u2019est e\u0301vident qu\u2019on ne peut pas s\u2019attendre a\u0300 une e\u0301valuation mirobolante \u00bb, a pre\u0301venu M. Cochat.<\/p>\n<p>Au sein du monde me\u0301dical, cette de\u0301cision a suscite\u0301 des re\u0301actions contraste\u0301s, entre convaincus et sceptiques du Leqembi. \u00ab Il y a quand me\u0302me une de\u0301ception \u00bb, admet aupre\u0300s de l\u2019AFP le chercheur Bruno Dubois, neurologue a\u0300 l\u2019ho\u0302pital de la Pitie\u0301-Salpe\u0302trie\u0300re (AP-HP), appelant a\u0300 ne pas ne\u0301gliger l\u2019inte\u0301re\u0302t de \u00ab quelques mois en plus a\u0300 pouvoir parler a\u0300 ses petits-enfants ou aller au the\u0301a\u0302tre \u00bb.<\/p>\n<p>Au contraire, \u00ab c\u2019est la meilleure de\u0301cision pour les patients atteints de la maladie d\u2019Alzheimer et leurs familles \u00bb, assure a\u0300 l\u2019AFP le psychiatre britannique Rob Howard, spe\u0301cialiste du grand a\u0302ge a\u0300 l\u2019University College de Londres, selon qui des donne\u0301es plus re\u0301centes confirment que Leqembi et Kisunla \u00ab ne modifient pas re\u0301ellement la maladie \u00bb.<\/p>\n<p><strong>Pour plus d&rsquo;informations et d&rsquo;analyses sur la <span style=\"color: #ff6600\">Senegal<\/span>, suivez <span style=\"color: #ff6600\">Africa-Press<\/span><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Africa-Press &#8211; Senegal. Le Leqembi, un nouveau traitement contre la maladie d\u2019Alzheimer, ne sera pas rembourse\u0301 dans l\u2019imme\u0301diat en France. Sa Haute autorite\u0301 de sante\u0301 (HAS) se montre sceptique, e\u0301voquant des effets secondaires bien trop lourds au regard de be\u0301ne\u0301fices insignifiants. \u00ab L\u2019acce\u0300s pre\u0301coce a\u0300 Leqembi n\u2019a pas e\u0301te\u0301 retenu \u00bb, a re\u0301sume\u0301 Pierre Cochat, [&hellip;]<\/p>\n","protected":false},"author":82,"featured_media":71089,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22,10],"tags":[44],"class_list":["post-71090","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-divers","category-toutes-les-actualites","tag-senegal-2"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.1 (Yoast SEO v27.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Alzheimer: la France Refuse le Traitement Leqembi - Senegal<\/title>\n<meta name=\"description\" content=\"Le Leqembi, un nouveau traitement contre la maladie d\u2019Alzheimer, ne sera pas rembourse\u0301 dans l\u2019imme\u0301diat en France. Sa H ...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alzheimer: la France Refuse le Traitement Leqembi\" \/>\n<meta property=\"og:description\" content=\"Le Leqembi, un nouveau traitement contre la maladie d\u2019Alzheimer, ne sera pas rembourse\u0301 dans l\u2019imme\u0301diat en France. Sa H ...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi\" \/>\n<meta property=\"og:site_name\" content=\"Senegal\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-09T12:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-10T00:15:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/09\/sm_1757490918.396057.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"cfeditorfr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"cfeditorfr\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi\"},\"author\":{\"name\":\"cfeditorfr\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\"},\"headline\":\"Alzheimer: la France Refuse le Traitement Leqembi\",\"datePublished\":\"2025-09-09T12:00:00+00:00\",\"dateModified\":\"2025-09-10T00:15:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi\"},\"wordCount\":844,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/09\/sm_1757490918.396057.jpg\",\"keywords\":[\"Senegal\"],\"articleSection\":[\"Divers\",\"Toutes les actualit\u00e9s\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi\",\"url\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi\",\"name\":\"Alzheimer: la France Refuse le Traitement Leqembi - Senegal\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/09\/sm_1757490918.396057.jpg\",\"datePublished\":\"2025-09-09T12:00:00+00:00\",\"dateModified\":\"2025-09-10T00:15:50+00:00\",\"author\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\"},\"description\":\"Le Leqembi, un nouveau traitement contre la maladie d\u2019Alzheimer, ne sera pas rembourse\u0301 dans l\u2019imme\u0301diat en France. Sa H ...\",\"breadcrumb\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#primaryimage\",\"url\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/09\/sm_1757490918.396057.jpg\",\"contentUrl\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/09\/sm_1757490918.396057.jpg\",\"width\":1200,\"height\":900,\"caption\":\"Alzheimer: la France Refuse le Traitement Leqembi\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.africa-press.net\/senegal\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alzheimer: la France Refuse le Traitement Leqembi\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#website\",\"url\":\"https:\/\/www.africa-press.net\/senegal\/\",\"name\":\"Africa Press | Senegal | Homepage\",\"description\":\"Just another Africa News Agency Sites site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.africa-press.net\/senegal\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\",\"name\":\"cfeditorfr\",\"url\":\"https:\/\/www.africa-press.net\/senegal\/author\/cfeditorfr\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Alzheimer: la France Refuse le Traitement Leqembi - Senegal","description":"Le Leqembi, un nouveau traitement contre la maladie d\u2019Alzheimer, ne sera pas rembourse\u0301 dans l\u2019imme\u0301diat en France. Sa H ...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi","og_locale":"fr_FR","og_type":"article","og_title":"Alzheimer: la France Refuse le Traitement Leqembi","og_description":"Le Leqembi, un nouveau traitement contre la maladie d\u2019Alzheimer, ne sera pas rembourse\u0301 dans l\u2019imme\u0301diat en France. Sa H ...","og_url":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi","og_site_name":"Senegal","article_published_time":"2025-09-09T12:00:00+00:00","article_modified_time":"2025-09-10T00:15:50+00:00","og_image":[{"width":1200,"height":900,"url":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/09\/sm_1757490918.396057.jpg","type":"image\/jpeg"}],"author":"cfeditorfr","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"cfeditorfr","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#article","isPartOf":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi"},"author":{"name":"cfeditorfr","@id":"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1"},"headline":"Alzheimer: la France Refuse le Traitement Leqembi","datePublished":"2025-09-09T12:00:00+00:00","dateModified":"2025-09-10T00:15:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi"},"wordCount":844,"commentCount":0,"image":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/09\/sm_1757490918.396057.jpg","keywords":["Senegal"],"articleSection":["Divers","Toutes les actualit\u00e9s"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi","url":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi","name":"Alzheimer: la France Refuse le Traitement Leqembi - Senegal","isPartOf":{"@id":"https:\/\/www.africa-press.net\/senegal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#primaryimage"},"image":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/09\/sm_1757490918.396057.jpg","datePublished":"2025-09-09T12:00:00+00:00","dateModified":"2025-09-10T00:15:50+00:00","author":{"@id":"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1"},"description":"Le Leqembi, un nouveau traitement contre la maladie d\u2019Alzheimer, ne sera pas rembourse\u0301 dans l\u2019imme\u0301diat en France. Sa H ...","breadcrumb":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#primaryimage","url":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/09\/sm_1757490918.396057.jpg","contentUrl":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/09\/sm_1757490918.396057.jpg","width":1200,"height":900,"caption":"Alzheimer: la France Refuse le Traitement Leqembi"},{"@type":"BreadcrumbList","@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/alzheimer-la-france-refuse-le-traitement-leqembi#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.africa-press.net\/senegal\/"},{"@type":"ListItem","position":2,"name":"Alzheimer: la France Refuse le Traitement Leqembi"}]},{"@type":"WebSite","@id":"https:\/\/www.africa-press.net\/senegal\/#website","url":"https:\/\/www.africa-press.net\/senegal\/","name":"Africa Press | Senegal | Homepage","description":"Just another Africa News Agency Sites site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.africa-press.net\/senegal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1","name":"cfeditorfr","url":"https:\/\/www.africa-press.net\/senegal\/author\/cfeditorfr"}]}},"_links":{"self":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/posts\/71090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/users\/82"}],"replies":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/comments?post=71090"}],"version-history":[{"count":0,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/posts\/71090\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/media\/71089"}],"wp:attachment":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/media?parent=71090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/categories?post=71090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/tags?post=71090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}